[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336397-105":59,"doc-detail-336397-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","radiochemotherapy-in-pancreatic-cancer","Radiochemotherapy in Pancreatic Cancer","","Despite advances in oncology, treatment of pancreatic cancer remains difficult, with five-year survival rates below 10%. Poor outcomes are linked to the tumor’s oligosymptomatic course, diagnostic challenges driven by anatomical location, and distinctive biological behavior. For resectable disease, standard care combines surgery with adjuvant chemotherapy, while unresectable or metastatic cases rely primarily on chemotherapy. Over decades, radiotherapy with systemic treatment has been explored, yet radiotherapy has no universally established role, motivating a review of its value alongside chemotherapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/radiochemotherapy-in-pancreatic-cancer/336397/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/radiochemotherapy-in-pancreatic-cancer/336397.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is pancreatic cancer treatment challenging?","Question",{"text":112,"@type":113},"Pancreatic cancer has five-year survival rates below 10% and is hard to treat due to limited symptom presentation, diagnostic difficulties from the organ’s anatomy, and unique tumor biology.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the standard treatment for resectable pancreatic cancer?",{"text":117,"@type":113},"Resectable disease is treated with primary surgery followed by adjuvant chemotherapy, aiming to improve outcomes after resection.",{"name":119,"@type":110,"acceptedAnswer":120},"How is unresectable or metastatic pancreatic cancer treated?",{"text":121,"@type":113},"Unresectable and metastatic cancers are primarily managed with chemotherapy, since surgery is not feasible as a curative option.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336397,1790443547,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Review  \nRadiochemotherapy in Pancreatic Cancer  \nMałgorzata Domagała-Haduch *, Anita Gorzelak-Magiera , Łukasz Michalecki and Iwona Gisterek-Grocholska   \nCitation: Domagała-Haduch, M.; Gorzelak-Magiera, A.; Michalecki, Ł.; Gisterek-Grocholska, I.  \nRadiochemotherapy in Pancreatic Cancer. Curr. Oncol. 2024, 31, 3291–3300. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol31060250  \nReceived: 29 April 2024  \nRevised: 23 May 2024  \nAccepted: 3 June 2024  \nPublished: 6 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Oncology and Radiotherapy, Medical University of Silesia, 40-514 Katowice, Poland;  \n[anitagor@op.pl](anitagor@op.pl) (A.G.-M.); [lukaszmichalecki@gmail.com](lukaszmichalecki@gmail.com) (Ł.M.); [igisterek@sum.edu.pl](igisterek@sum.edu.pl) (I.G.-G.)  \n* [Correspondence: malgorzatadom@interia.pl](Correspondence: malgorzatadom@interia.pl)  \nAbstract: Despite the advancements made in oncology in recent years, the treatment of pancreatic cancer remains a challenge. Five-year survival rates for this cancer do not exceed 10% . Among the reasons contributing to poor treatment outcomes are the oligosymptomatic course of the tumor, diagnostic difficulties due to the anatomical location of the organ, and the unique biological features of pancreatic cancer. The mainstay of treatment for resectable cancer is surgery and adjuvant chemotherapy. For unresectable and metastatic cancers, chemotherapy remains the primary method of treatment. At the same time, for about thirty years, there have been attempts to improve treatment outcomes by using radiotherapy combined with systemic treatment. Unlike chemotherapy, radiotherapy has no established place in the treatment of pancreatic cancer. This paper addresses the topic of radiotherapy in pancreatic cancer as a valuable method that can improve treatment outcomes alongside chemotherapy.  \nKeywords: radiochemotherapy; unresectable pancreatic cancer; resectable pancreatic cancer; borderline resectable pancreatic cancer; chemotherapy  \n1. Introduction  \nPancreatic adenocarcinoma is one of the most poorly treatable cancers. Five-year survival rates for this cancer do not exceed 10%[1] . With an annual death toll of about 128,000, the cancer ranks as the fourth most common cause of cancer death [2] .  \nIt is estimated that pancreatic cancer will become the second cause of cancer deaths in 2030 [3] .  \nThe only method to achieve long-term survival is primary surgery with subsequent follow-up chemotherapy. Unfortunately, due to the oligosymptomatic progression of the disease, resectable cancer is diagnosed in 10–20% of patients. About 40% of patients are diagnosed with stage IV disease, while 40–50% of patients have locoregional, inoperable pancreatic cancer at the time of diagnosis [4] .  \nThe most important criterion for unresectability of pancreatic cancer is infiltration of the surrounding arterial and venous vessels. Based on the type of vessels involved and the extent of infiltration, pancreatic cancer has been divided into resectable, borderline resectable, and unresectable [5,6] .  \nThis article discusses the role of radiochemotherapy in the treatment of pancreatic cancer according to the stage of the tumor.  \n2. Resectable Pancreatic Cancer  \nResectable pancreatic cancer is defined as a lesion that does not infiltrate the vessels of the visceral trunk, superior mesenteric artery, or common hepatic artery. As regards the venous vessels, the lesion must not infiltrate the superior mesenteric vein or portal vein (involvement of \u003C180◦ of these vessels without obliteration of their wall is allowed) [6] .  \nIn resectable ","cbCaissqfb0n1Csf","https://ap.wps.com/l/cbCaissqfb0n1Csf","pdf",239140,"English","# Introduction\n## Resectable Pancreatic Cancer","[{\"question\":\"Why is pancreatic cancer treatment challenging?\",\"answer\":\"Pancreatic cancer has five-year survival rates below 10% and is hard to treat due to limited symptom presentation, diagnostic difficulties from the organ’s anatomy, and unique tumor biology.\"},{\"question\":\"What is the standard treatment for resectable pancreatic cancer?\",\"answer\":\"Resectable disease is treated with primary surgery followed by adjuvant chemotherapy, aiming to improve outcomes after resection.\"},{\"question\":\"How is unresectable or metastatic pancreatic cancer treated?\",\"answer\":\"Unresectable and metastatic cancers are primarily managed with chemotherapy, since surgery is not feasible as a curative option.\"}]","Radiochemotherapy in Pancreatic Cancer | PDF",1790014867,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8a105af41260d5c07218fb7d9942fc3.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13df3611445cfb6a07292d08183536e9.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04f2c0fefa782c641463add3f832d6b0.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef2668dcad77f9d835c65042674e5ef8.webp",980,1385]